Skip to content

Industry Event

FDA Public Workshop: “COVID-19 Lessons Learned: Clinical Evaluation of Therapeutics”

Join federal leadership and key stakeholders on September 28 for the virtual FDA public workshop “COVID-19 Lessons Learned: Clinical Evaluation of Therapeutics.” The event will disseminate findings from the Federal COVID-19 Response or Countermeasures Acceleration Groups (formerly known as Operation Warp Speed) to bring relevant therapeutics to use in the next public health emergency.

Presenters will distill learnings from months of interviews, discussions, and materials review into actionable recommendations to enhance scoping, prioritizing, and communicating about research activities in a public health emergency setting. Register for the workshop to explore the findings, ask questions of the stakeholders, and share your public comments. Keynote speakers are Janet Woodcock, MD, Acting Commissioner, U.S. Food & Drug Administration, and Francis S. Collins, MD, Ph.D., Director, National Institutes of Health.

TransCelerate Chief Operating Officer Janice Chang will be speaking on the “Clinical Trial Execution Panel.” Other speakers on the panel include Samuel Brown, MD, MS, Attending Physician, Intermountain Medical Center and Assistant Professor of Pulmonary and Critical Care, University of Utah School of Medicine Intermountain; Monica Webb Hooper, Ph.D., Deputy Director, National Institute on Minority Health and Health Disparities; and Kate Zenlea, MPH, CPH, Managing Director, The Global Health Initiative at Henry Ford Health System.